Resective surgical approach shows a high performance in the management of advanced cases of bisphosphonate-related osteonecrosis of the jaws: A retrospective survey of 347 cases

Journal of Oral and Maxillofacial Surgery

Volumn 70, Issue 11, 2012, Pages 2501-2507

  Graziani, Filippo ^a   Vescovi, Paolo ^b   Campisi, Giuseppina ^c   Favia, Gianfranco ^d   Gabriele, Mario ^a   Gaeta, Giovanni Maria ^e   Gennai, Stefano ^f   Goia, Franco ^g   Miccoli, Mario ^a   Peluso, Franco ^h   Scoletta, Matteo ⁱ   Solazzo, Luigi ^j   Colella, Giuseppe ^e  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d UNIVERSITY OF BARI   (Italy)

^e SECOND UNIVERSITY OF NAPLES   (Italy)

^f UNIVERSITY OF MILANO BICOCCA   (Italy)

^g MAURIZIANO HOSPITAL   (Italy)

^h San Sebastiano Hospital   (Italy)

ⁱ UNIVERSITY OF TURIN   (Italy)

^j ARNAS Ospedale Civico   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; IBANDRONIC ACID; NERIDRONIC ACID; PAMIDRONIC ACID; RISEDRONIC ACID; ZOLEDRONIC ACID;

ADULT; AGED; ARTICLE; BONE RESECTION; CANCER CHEMOTHERAPY; COHORT ANALYSIS; CORTICOSTEROID THERAPY; DEBRIDEMENT; DIABETES MELLITUS; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; JAW OSTEONECROSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MANDIBLE; MAXILLA; MAXILLOFACIAL SURGERY; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDY; SURGICAL APPROACH; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

ADULT; AGED; ANALYSIS OF VARIANCE; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; CHI-SQUARE DISTRIBUTION; DEBRIDEMENT; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; OSTEOTOMY; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SURGICAL PROCEDURES, OPERATIVE; TOOTH EXTRACTION; TREATMENT OUTCOME;

EID: 84867571111     PISSN: 02782391     EISSN: 15315053     Source Type: Journal    
DOI: 10.1016/j.joms.2012.05.019     Document Type: Article

References (36)

1. J.F. Bukowski, C.C. Dascher, H. Das Alternative bisphosphonate targets and mechanisms of action Biochem Biophys Res Commun 328 2005 746
2. A.A. Reszka, G.A. Rodan Mechanism of action of bisphosphonates Curr Osteoporos Rep 1 2003 45
3. H.A. Fleisch Bisphosphonates: Preclinical aspects and use in osteoporosis Ann Med 29 1997 55
4. I.J. Diel, E.F. Solomayer, G. Bastert Bisphosphonates and the prevention of metastasis: First evidences from preclinical and clinical studies Cancer 88 2000 3080
5. G. Campisi, O. Di Fede, A. Musciotto Bisphosphonate-related osteonecrosis of the jaw (BRONJ): Run dental management designs and issues in diagnosis Ann Oncol 18 suppl 6 2007 vi168
6. C. Hewitt, C.S. Farah Bisphosphonate-related osteonecrosis of the jaws: A comprehensive review J Oral Pathol Med 36 2007 319
7. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws J Maxillofac Surg 65 2007 369
8. S. Fedele, S.R. Porter, F. D'Aiuto Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: A case series Am J Med 123 2010 1060
9. L. Junquera, L. Gallego Nonexposed bisphosphonate-related osteonecrosis of the jaws: Another clinical variant? J Oral Maxillofac Surg 66 2008 1516
10. R.E. Marx, J.E. Cillo Jr, J.J. Ulloa Oral bisphosphonate-induced osteonecrosis: Risk factors, prediction of risk using serum CTX testing, prevention, and treatment J Oral Maxillofac Surg 65 2007 2397
11. J.J. Freiberger Utility of hyperbaric oxygen in treatment of bisphosphonate-related osteonecrosis of the jaws J Oral Maxillofac Surg 67 2009 96
12. P. Vescovi, M. Manfredi, E. Merigo Surgical approach with Er:YAG laser on osteonecrosis of the jaws (ONJ) in patients under bisphosphonate therapy (BPT) Lasers Med Sci 25 2010 101
13. R.A. Williamson Surgical management of bisphosphonate induced osteonecrosis of the jaws Int J Oral Maxillofac Surg 39 2010 251
14. E.R. Carlson, J.D. Basile The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws J Oral Maxillofac Surg 67 2009 85
15. P. Vescovi, E. Merigo, M. Meleti Bisphosphonate-associated osteonecrosis (BON) of the jaws: A possible treatment? J Oral Maxillofac Surg 64 2006 1460
16. S.L. Ruggiero, T.B. Dodson, L.A. Assael American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws - 2009 update J Oral Maxillofac Surg 67 2009 2
17. F. Wilde, M. Heufelder, K. Winter The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw Oral Surg Oral Med Oral Pathol Oral Radiol Endod 111 2011 153
18. M. Scoletta, P.G. Arduino, P. Dalmasso Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: A prospective study Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110 2010 46
19. M.H. Abu-Id, P.H. Warnke, J. Gottschalk "Bis-phossy jaws" - High and low risk factors for bisphosphonate-induced osteonecrosis of the jaw J Craniomaxillofac Surg 36 2008 95
20. R.E. Marx, Y. Sawatari, M. Fortin Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment J Oral Maxillofac Surg 63 2005 1567
21. S.L. Ruggiero, B. Mehrotra, T.J. Rosenberg Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases J Oral Maxillofac Surg 62 2004 527
22. A. Bedogni, G. Saia, G. Bettini Long-term outcomes of surgical resection of the jaws in cancer patients with bisphosphonate-related osteonecrosis Oral Oncol 47 2011 420
23. D.C. Stanton, E. Balasanian Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: Review of 33 surgical cases J Oral Maxillofac Surg 67 2009 943
24. P. Stockmann, E. Vairaktaris, F. Wehrhan Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: A prospective clinical study with 12 months follow-up Support Care Cancer 18 2010 449
25. F. Graziani, S. Cei, F. La Ferla Association between osteonecrosis of the jaws and chronic high-dosage intravenous bisphosphonates therapy J Craniofac Surg 17 2006 876
26. A. Wutzl, E. Biedermann, F. Wanschitz Treatment results of bisphosphonate-related osteonecrosis of the jaws Head Neck 30 2008 1224
27. V. Thumbigere-Math, M.C. Sabino, R. Gopalakrishnan Bisphosphonate-related osteonecrosis of the jaw: Clinical features, risk factors, management, and treatment outcomes of 26 patients J Oral Maxillofac Surg 67 2009 1904
28. A.O. Hoff, B. Toth, M. Hu Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients Ann N Y Acad Sci 1218 2011 47
29. S. Otto, M.H. Abu-Id, S. Fedele Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: Not just a sporadic coincidence - A multi-centre study J Craniomaxillofac Surg 1 2010 45
30. C.T. Chiu, W.F. Chiang, C.Y. Chuang Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw - A serial case analysis J Oral Maxillofac Surg 68 2010 1055
31. C.L. Estilo, C.H. Van Poznak, T. Wiliams Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy Oncologist 13 2008 911
32. Y. Assouline-Dayan, C. Chang, A. Greenspan Pathogenesis and natural history of osteonecrosis Semin Arthritis Rheum 32 2002 94
33. J.V. Bagan, Y. Jiménez, D. Gómez Collagen telopeptide (serum CTX) and its relationship with the size and number of lesions in osteonecrosis of the jaws in cancer patients on intravenous bisphosphonates Oral Oncol 44 2008 1088
34. K.E. Fleisher, G. Welch, S. Kottal Predicting risk for bisphosphonate-related osteonecrosis of the jaws: CTX versus radiographic markers Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110 2010 509
35. T.S. Lazarovici, S. Mesilaty-Gross, I. Vered Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates J Oral Maxillofac Surg 68 2010 2241
36. S. Lehrer, A. Montazem, L. Ramanathan Normal serum bone markers in bisphosphonate-induced osteonecrosis of the jaws Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106 2008 389